Tularemia vaccine: Safety, reactogenicity, “Take” skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial

Tularemia vaccine: Safety, reactogenicity, “Take” skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Vaccine - Volume 35, Issue 36, 24 August 2017, Pages 4730-4737

Mark J. Mulligan, Jack T. Stapleton, Wendy A. Keitel, Sharon E. Frey, Wilbur H. Chen, Nadine Rouphael, Srilatha Edupuganti, Allison Beck, Patricia L. Winokur, Hana M. El Sahly, Shital M. Patel, Robert L. Atmar, Irene Graham, Edwin Anderson,